A total of 38 papers identified the ten most frequently reported measurable risk factors for medication-related issues (all international definitions included), all of which may be identified from hospital inpatient records. |
Twenty-eight of these papers identified the ten most frequently reported drugs or classes of drug associated with medication-related issues; further work is required to quantify these risks. |
No papers discussed the risk factors associated with the requirement for pharmacist intervention. This may be because of poor evidence for an association of pharmacist interventions with a reduction in medicines-related incidents. |
1 Introduction
1.1 Background
1.2 Aims
1.3 Objectives
2 Methods
2.1 Eligibility Criteria
2.1.1 Paper Inclusion Criteria
2.1.2 Paper Exclusion Criteria
2.1.3 Search Terms
2.2 Information Sources
2.3 Study Selection
2.4 Data Collection Process
2.5 Synthesis of Results
References | Study setting | Study design | Size of study | Drugs | PolyPharm | Age | Renal | Female | Co-morbids | Length of stay | Hx of allergy | Liver | Compliance | Other | Limitations to study |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alderman and
Farmer [21] | Australian Teaching Hospital | SCS Prospective study of prevalence of pharmacy interventions with manual collection of data | 67 interventions |
✓
| SCS only. Sample size very small. No denominator (number. of interventions may be affected by prescription rate) | ||||||||||
Al-Hajje et al. [22] | Beruit University Hospital | SCS Prospective study involving clinical pharmacy students trained to identify DRPs on a medical ward round and analysis of resulting interventions | 90 DRPs in 572 patients |
✓
| No denominator (increase in percentage of DRPs related to a particular drug may be due to an increased number of prescriptions for that drug) | ||||||||||
Bates et al. [23] | U.S. Medical and surgical inpatients | Two Tertiary care hospitals—two methods used: 1. Cohort study 2. Nested matched case control study | Method 1 = 2109 Method 2 = 247 of 4108 total admissions |
✓
|
✓
|
✓
| Only two tertiary centres which may hinder generalizability to other care settings. Cohort analysis looked only at information available electronically | ||||||||
Blix et al. [24] | Five General Hospital—Norway | MCS–Medical inpatients excluding A&E departments Prospective manual recording of assumed clinical and pharmacological risk factors. Impact of various risk factors on occurrence of different categories of DRPs using multivariate analysis | 827 patients |
✓
|
✓
|
×
|
✓
|
✓
|
✓
|
✓
|
✓
| ||||
Bowman et al. [25] | US General Hospital | SCS medical inpatients. Prospective drug chart review. Univariate logistic regression to identify covariate predictors of ADR from laboratory, demographic and total drug exposure. Stepwise multivariate logistic regression to identify those univariate indicators that best predict ADR occurence | 1024 patients |
✓
|
×
|
✓
|
✓
| SCS only | |||||||
Bowman et al. [26] | US General Hospital | SCS medical inpatients. Prospective observational study using manual chart review by pharmacists | 304 ADRs in a total of 1024 patients |
✓
|
✓
|
✓
| The study is quite old and SCS only so that drugs used in the study may differ somewhat from those used 20 years on | ||||||||
Calderón-Ospina and Bustamante-Rojas [27] | US University Hospital | SCS Prospective study including manual independent assessment of adult inpatients. All reports of ADRs subsequently evaluated by three independent researchers | 102 patients |
✓
|
✓
|
✓
| Small sample size may have led to overestimation of percentage of cases | ||||||||
Camargo et al. [28] | Brazilian University Hospital | SCS Cohort study using logistic regression analysis to identify risk factors. Factors demonstrating significant association with an ADR were included in the multivariate logistic regression model | 360 ADRs |
✓
|
✓
|
×
|
×
|
×
|
✓
| 19.7% of the ADRs were prior to admission, this review is primarily focused on ADRs in the inpatient setting | |||||
Carbonin et al. [29] | Italy—General hospital—medical and geriatric wards | MCS Prospective study using clinician identification of ADR, logistic regression to determine risk factors and multivariate logistic regression to identify independent risk factors | 788 ADRs from 9148 admissions |
✓
|
×
|
✓
|
✓
|
✓
| ADRs may have been under reported as relying on physician reporting | ||||||
Classen et al. [30] | US Tertiary Care Centre | SCS Prospective study of all patients admitted over an 18 month period | 648 patients with ADEs in a total of 36,653 admitted patients |
✓
|
✓
|
✓
| Authors acknowledge that age may not be an independent risk factor; further studies required to investigate this. Number of ADEs identified appears low and potentially, minor ADEs may have been undetected by this method | ||||||||
Claydon-Platt et al. [31] | Australian Teaching Hospital | SCS conducted over 2 years Retrospective cohort study of medication-related problems in inpatients with diabetes. Risk factors associated with medication-related problems were identified using random effect logistic regression | 571 patients in a total of 5205 admitted patients |
✓
|
✓
|
✓
|
✓
| Data used was collected for other purposes so links to other risk factors may have been omitted. Risk factors in diabetes may not be valid in other cohorts | |||||||
Davies et al. [32] | UK University Hospital | SCS over a 6 month period Prospective cohort study of ADRs. Risk factors for ADRs were identified using multivariable analysis | 545 patients from 3695 patient episodes |
✓
|
✓
|
✓
|
✓
|
✓
| SCS, likely to be variation between different hospitals because of the differences in the local population characteristics and specialities within the hospitals | ||||||
Dequito et al. [33] | Holand—General Hospitals | Two Dutch hospitals using CPOE—5 month data collection Prospective cohort study Univariante analysis followed by multivariante analysis analysis was performed using a logistic regression to establish independent risk factors for preventable ADEs and non-preventable ADRs | 349 patients from 603 admissions |
✓
|
✓
|
✓
|
✓
|
✓
|
✓
|
✓
| Only gastroenterology, rheumatology, geriatrics and internal medical patients included. Results may not be transferable to other specialities and hospitals | ||||
Fattinger et al. [34] | Switzerland Teaching Hospital | Two teaching hospitals. Prospective cohort study using a purpose built database. Clinical events were reported in a separate database by separate personnel to avoid bias. Regression analysis used to identify risk factors | 2102 patients of 4331 admissions |
✓
|
✓
|
×
|
✓
| ADRs included “accepted” side-effects e.g. Nausea and vomiting from chemotherapy | |||||||
Fields et al. [35] | United States Community Hosiptal | Two community non-teaching hospitals. Prospective study using a multi-method approach—voluntary self-reports, e-prescribing, laboratory triggers and pharmacist intervention surveillance | 1052 medication safety events; of these 318 were classified as errors |
✓
| Analysed data from medication errors only and did not address other ADEs | ||||||||||
Gurwitz and Avorn [36] | United States | Literature review examining the association of age with ADRs Medline search for articles between 1966 and 1990 |
×
| Review over 20 years old but principles likely to still apply | |||||||||||
Hoonhout et al. [37] | Netherlands | MCS Analysis of MRAEs identified by retrospective chart review of patients admitted to 21 hospitals in 2004 | 140 patients of 7889 admissions |
✓
|
✓
| Difficult to make comparisons to other studies due to differing definition of MRAEs; however, conclusions look similar to other studies | |||||||||
Hurwitz [38] | Irish University Hospital | SCS Prospective study using a rank correlation to determine relationship between age, sex, length of stay in hospital, no. of drugs, history of previous drug reactions, allergic disease, jaundice, diabetes and renal disease | 118 ADRs from 1160 patients |
✓
|
✓
|
✓
|
✓
| SCS from 1969. Are the same factors relevant with the differing drug groups available in the inpatient setting today? | |||||||
Hurwitz and Wade [39] | Irish General Hospital | SCS Prospective study of patients admitted to surgical and medical wards by means of case note review and patient interview | 118 patients of 1160 patients receiving drugs |
✓
| SCS from 1969. Are the same factors relevant with the differing drug groups available in the inpatient setting today? | ||||||||||
Johnston et al. [40] | US University Hospital | SCS Prospective analysis of AE reports. A three stage logistic regression model used to evaluate key indicators of the most vulnerable patient populations | 59,531 admissions, including 782 AEs which included 83 ADRs and 699 errors |
✓
|
✓
|
✓
|
×
|
✓
| The number of ADRs in this study was small (only 83) while the study mainly collected data on medication errors | ||||||
Kanjanarat et al. [41] | United States | Literature review Key word search of Medline and International Pharmaceutical Abstracts and by manual search | Ten studies between 1994 and 2001 |
✓
| Only 10 studies reviewed. Does not include more recent work and therefore does not cover newer therapies | ||||||||||
Kelly [42] | Study from Clin-Alert, an abstracting service in the US | Retrospective study of case reports of fatal ADEs published between 1976 and 1995 | 447 cases involving a fatal ADE |
✓
|
✓
| No denominator. An increase of fatal ADEs may have been attributable to the number of prescriptions in the respective class | |||||||||
Kelly [43] | Study from Clin-Alert, an abstracting service in the US | Retrospective study of case reports of drug-induced permanent disabilities published between 1978 and 1997 | 227 cases involving a drug-induced permanent disability |
✓
|
✓
| No denominator. An increase in disabilities may have been attributable to the number of prescriptions in the respective class. Study includes children which this systematic review excludes | |||||||||
Krähenbühl-Melcher et al. [44] | Switzerland | Literature review Electronic Search using Medline and Embase for articles published between 1990 and 2005. Subsequent manual search of resulting articles for original research | 11 studies reporting risk factors for ADRs |
✓
|
✓
|
✓
|
✓
|
✓
|
✓
| Comprehensive review but excludes drugs to market post 2005 | |||||
Marcellino and Kelly [45] | Study from Clin-Alert, an abstracting service in the US | Retrospective study of case reports of drug-induced threats to life published between 1977 and 1997 | 846 drug-induced life threats |
✓
| No denominator. An increase in life threats may have been attributable to the number of prescriptions in the respective class or that the associated condition treated was a risk to life | ||||||||||
O’Connor et al. [46] | Irish University Hospital | SCS. Study to examine the GerontoNet ADR risk score in elderly patients. Prospective study, ADRs identified through patient and physician consultation and case note analysis. Multivariate logistic regression examined influence of individual variables on ADRs | 135 ADRs from 513 acutely ill patients |
✓
|
✓
|
✓
|
✓
| Sample size quite small and single centre only | |||||||
Onder et al. [18] | Italy | MCS—four European university hospitals. Data from an Italian Research Group used to identify variables associated with ADRs using stepwise logistic regression and used to compute the ADR risk score. The risk score was then validated in a sample of older adults | 383 ADRs in 5936 patients |
✓
|
✓
|
✓
|
✓
|
✓
| Risk score may not be relevant in the under 65 age group and the risk score excludes any other risk factors | ||||||
Pearson et al. [47] | US Community Hospital | SCS. Retrospective analysis of ADRs through internal voluntary reporting system. Patient characteristics compared for patients experiencing preventable and non-preventable ADRs | 203 |
✓
|
✓
|
✓
|
✓
| Reliance on voluntary reporting of ADRs. Actual number of ADRs may have been much higher resulting in a small sample size. Although the ADRs were all independently reviewed, all the reviewers were pharmacists which may have introduced bias. Single centre only | |||||||
Runciman [48] | Australia | Literature review of systematic reviews and national data collections | 53,388 ADRs as part of routine national data collection |
✓
| Review does include community data but the studies are separated out in the review to detail specifics in secondary care | ||||||||||
Samuel et al. [49] | Two General Hospitals in India | Two sites. Prospective study post introduction of an ADR monitoring programme. Manual reporting of ADRs and patient interview | 152 ADRs |
✓
| Includes some data from the outpatient setting. No denominator i.e. number of ADRs recorded with probable causative agent but no record of number of prescriptions for respective agent | ||||||||||
Schimmel [50] | US University Hospital | Reprint of Annals of Internal Medicine, 1964, volume 60, pages 100–110. Prospective study. Recording by house officers of all noxious events in patients admitted under them | 119 ADEs |
✓
|
✓
| Excludes ADEs which did not have a harmful outcome, e.g. if the house officer altered treatment before an adverse incident occurred. Does not report a rate of ADEs for each drug, i.e. no denominator. Relevance now with new drug groups available? Also single centre | |||||||||
Smith et al. [51] | US University Hospital | SCS. Prospective study with manual chart review | 151 drug reactions in 900 patients |
✓
|
✓
|
✓
|
×
|
✓
|
✓
| Only rate of reactions reported, multivariate logistic regression required to determine if independent risk factors. 1965 study and drug groups used today have altered somewhat | |||||
Steel [52] | United States | Reprint of the New England Journal of Medicine, 1981, volume 304, pages 638–42. Prospective study of medical pts.—manual review of case notes vs. a standardised 27 item instrument to identify iatrogenic issues. Hospital interventions categorised and included no. and type of drugs | 290 pts experiencing iatrogenic illness. 208 caused by drugs |
✓
| Study from 1979. Drugs prescribed today may result in greater or less risk. No denominator included to determine rate of ADRs. Unclear if the study covered ADEs such as hypoglycaemia with insulin? Is this covered by the definition of iatrogenic illness? | ||||||||||
Tegeder et al. [53] | University Hospital, Germany | SCS. Retrospective case note analysis to assess if changes in lab data due to ADR and if physician recognised this | 294 patients |
✓
| Small sample size. Changes in lab data may be a consequence of the ADR and not a pre-disposing risk factor for developing an ADR | ||||||||||
Van den Bemt et al. [54] | Dutch General Hospital | Study in two Dutch general hospitals | 149 ADEs in 538 patients |
✓
|
✓
|
✓
| Study from 1996 so groups of drugs prescribed may now be a little outdated | ||||||||
Van Kraaij et al. [55] | Dutch General Hospital | SCS. Patients 65 years and over. Naranjo’s algorithm used to estimate the probability of adverse event being attributable to a drug. Multiple regression analysis used to measure interrelationships between variables | 120 ADRs in 105 patients |
✓
|
×
| Study only includes patients 65 years and over. Only single centre and medical patients only included | |||||||||
Viktil et al. [56] | Norwegian General Hospitals | MCS—five sites. Prospective cohort study using manual case note/chart review by the MDT. Univariate analysis and a multivariate logistic regression to assess influence of gender, age and clinical risk factors on nos of drugs prescribed | 827 patients |
✓
| Drug discontinuations during hospital stay not recorded | ||||||||||
Wiffen et al. [57] | Systematic review of the literature Comprehensive search of MEDLINE (1966–1999), EMBASE (1980–1999) and International Pharmaceutical Abstracts (1970–1999) |
✓
|
✓
|
✓
|
✓
|
✓
|
✓
|
✓
| Excludes studies post 2000. Most studies cited refer to elderly pts only which excludes drugs and characteristics common in the young | ||||||
28 | 18 | 14 | 9 | 9 | 7 | 5 | 4 | 3 | 3 | 10 |
✓ Positive Associations | ||||
0 | 0 | 7 | 0 | 2 | 1 | 0 | 1 | 0 | 0 | 0 | × Negative Associations |
References | Antimicrobials | Thrombolytics/anticoagulants | Cardiovascular | CNS agents | Diuretics | Corticosteroids | Chemotherapy | Opiates | Anti-epileptics | Insulin/hypoglycaemics | Anti-inflammatories/NSAIDs | Other |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Alderman and Farmer [21] |
✓
|
✓
| ||||||||||
Al-Hajje et al. [22] |
✓
|
✓
|
✓
| |||||||||
Blix et al. [24] |
✓
|
✓
|
✓
|
✓
| Theophylline, allopurinol, potassium, and levothyroxine | |||||||
Bowman et al. [26] |
✓
|
✓
|
✓
| |||||||||
Calderón-Ospina and Bustamante-Rojas [27] |
✓
|
✓
|
✓ Beta blockers |
✓
|
✓
| |||||||
Camargo et al. [28] |
✓
|
✓
| ||||||||||
Classen et al. [30] |
✓
|
✓
|
✓
|
✓
| ||||||||
Davies et al. [32] |
✓
|
✓
|
✓
|
✓
|
✓
| |||||||
Dequito et al. [33] |
✓
| |||||||||||
Fattinger et al. [34] |
✓
| |||||||||||
Hoonhout et al. [37] |
✓
|
✓
|
✓
| |||||||||
Hurwitz and Wade [39] | Digitalis, bronchodilators and ampicillin | |||||||||||
Johnston et al. [40] |
✓
|
✓
|
✓
|
✓
|
✓
|
✓
| Lorazepam, theophylline, cyclosporin | |||||
Kanjanarat et al. [41] |
✓
|
✓
|
✓
|
✓
|
✓
| |||||||
Kelly [42] |
✓
|
✓
|
✓
|
✓
| ||||||||
Kelly [43] |
✓
|
✓
|
✓
| Vaccines | ||||||||
Krähenbühl-Melcher et al. [44] |
✓
|
✓
|
✓
| |||||||||
Marcellino and Kelly [45] |
✓
|
✓
| ||||||||||
O’Connor et al. [46] |
✓
|
✓
| Benzodiazepines | |||||||||
Pearson et al. [47] |
✓
| |||||||||||
Runciman [48] |
✓
|
✓
|
✓
|
✓
|
✓
|
✓
|
✓
|
✓
|
✓
|
✓
|
✓
| |
Samuel et al. [49] |
✓
|
✓
|
✓
|
✓
| ||||||||
Schimmel [50] |
✓
|
✓
|
✓
|
✓
|
✓
|
✓
| ||||||
Smith et al. [51] |
✓
|
✓
|
✓
|
✓
|
✓
|
✓
|
✓
| |||||
Steel [52] |
✓
|
✓
|
✓
|
✓
| Aminophylline | |||||||
Van den Bemt et al. [54] |
✓
|
✓
|
✓
|
✓
| GI drugs | |||||||
Van Kraaij et al. [55] |
✓
| |||||||||||
Wiffen et al. [57] |
✓
|
✓
|
✓
|
✓
|
✓
|
✓
| ||||||
19 | 16 | 13 | 12 | 8 | 8 | 7 | 5 | 5 | 5 | 4 | Total no. of studies with positive association with the drug group |